A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus
Clinical trial NCT00002095 · COMPLETED
Trial details
- NCT number
- NCT00002095
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.